Literature DB >> 3363809

Encephalomyelitis, reproductive failure and corneal opacity (blue eye) in pigs, associated with a paramyxovirus infection.

H A Stephan1, G M Gay, T C Ramírez.   

Abstract

A new clinicopathological disorder associated with a paramyxovirus infection in pigs is described. Central nervous system manifestations and corneal opacity are the main features in piglets two to 21 days old. Older pigs seem to be more resistant and only corneal opacity is commonly observed. In pregnant sows the virus appears to be responsible for reproductive disturbances such as stillbirth, mummification and a return to oestrus. The changes are mainly microscopic and characterised by a non-suppurative encephalomyelitis, interstitial pneumonia and anterior uveitis with corneal oedema. Experimental infection of one-day-old piglets with the virus reproduced clinical signs similar to those described in naturally infected piglets. The virus was recovered from the tonsils, lung and brain of the experimentally infected piglets between the fourth and 20th day after infection.

Entities:  

Mesh:

Year:  1988        PMID: 3363809     DOI: 10.1136/vr.122.1.6

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  19 in total

1.  Analysis of the fusion protein gene of the porcine rubulavirus LPMV: comparative analysis of paramyxovirus F proteins.

Authors:  M Berg; A C Bergvall; M Svenda; A Sundqvist; J Moreno-López; T Linné
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  The haemagglutinin-neuraminidase glycoprotein of the porcine paramyxovirus LPMV: comparison with other paramyxoviruses revealed the closest relationship to simian virus 5 and mumps virus.

Authors:  A Sundqvist; M Berg; J Moreno-López; T Linné
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Outbreak of meningitis in weaner pigs caused by unidentified asaccharolytic gram-negative bacterium.

Authors:  K Mohan; B Holmes; N Kock; P Muvavarirwa
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  The porcine paramyxovirus LPM specifically recognizes sialyl (alpha 2,3) lactose-containing structures.

Authors:  J Reyes-Leyva; P Hernández-Jáuregui; L F Montaño; E Zenteno
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Purification and characterization of the hemagglutinin-neuraminidase of Porcine rubulavirus LPMV.

Authors:  J Reyes-Leyva; B Espinosa; G Santos; R Zenteno; J Hernández; V Vallejo; E Zenteno
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

6.  Establishment and characterisation of a porcine rubulavirus (LPMV) persistent infection in porcine kidney cells.

Authors:  B Hjertner; T Linné; J Moreno-López
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

7.  Genetic and antigenic changes in porcine rubulavirus.

Authors:  José I Sánchez-Betancourt; María E Trujillo; Susana E Mendoza; Julio Reyes-Leyva; Rogelio A Alonso
Journal:  Can J Vet Res       Date:  2012-01       Impact factor: 1.310

8.  Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation.

Authors:  Rebecca Crepeau; Abraham Matar; Thomas R Spitzer; Simon Robson; Vimukthi Pathiraja; David H Sachs; Christene A Huang; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

9.  Canine distemper virus infection and encephalitis in javelinas (collared peccaries).

Authors:  M J Appel; C Reggiardo; B A Summers; S Pearce-Kelling; C J Maré; T H Noon; R E Reed; J N Shively; C Orvell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation.

Authors:  Giuseppe Pisanelli; Maudry Laurent-Rolle; Balaji Manicassamy; Alan Belicha-Villanueva; Juliet Morrison; Bernardo Lozano-Dubernard; Felipa Castro-Peralta; Giuseppe Iovane; Adolfo García-Sastre
Journal:  Virus Res       Date:  2015-11-03       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.